glutathione drug release responsive nanomedicine leverages tumor redox imbalance for targeted cancer theranostics | Discover Oncology Glutathione-responsive cyclodextrin-nanosponges as drug delivery

A total of 50 L of 1-chloro-2,4-dinitrobenzene at 20 mmol/L was mixed with 850 L of 0.1 mol/L phosphate buffer (pH 6.5)

"These statements have not been evaluated by the Food and Drug Administration

and the 2025 Monitoring Program, which includes substances that are not on the List, but that WADA wishes to monitor in order to detect potential patterns of misuse in sport

Ferguson LR, Browning BL, Huebner C, Petermann I, Shelling AN, Demmers P, McCulloch A, Gearry RB, Barclay ML, Philpott M: Single nucleotide polymorphisms in human Paneth cell defensin A5 may confer susceptibility to inflammatory bowel disease in a New Zealand Caucasian population